Hormone replacement therapy: Assessment of present use, costs, and trends

British Journal of General Practice

Volumn 48, Issue 427, 1998, Pages 955-958

  Townsend, Joy ^a  

^a UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

Costs; Hormone replacement therapy; Prescribing trends; Prevalence

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DATA ANALYSIS; FEMALE; GOVERNMENT; HEALTH CARE COST; HEALTH CARE UTILIZATION; HORMONE SUBSTITUTION; HUMAN; LONG TERM CARE; OSTEOPOROSIS; PRESCRIPTION; PREVENTIVE MEDICINE; UNITED KINGDOM;

ADULT; DRUG COSTS; ESTROGEN REPLACEMENT THERAPY; FEMALE; FORECASTING; GREAT BRITAIN; HUMANS; LONG-TERM CARE; MIDDLE AGED;

EID: 0031931929     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hunt K, Vessey M. Long term effects of postmenopausal hormone therapy. Br J Hosp Med 1987; 38: 450-460.
2. Hunt K, Vessey M, McPherson K, Coleman M. Long term surveillance of mortality and cancer incidence in women receiving HRT. Br J Obstet Gynaecol 1987; 94: 620-635.
3. The PEPI Investigators. Effects of estrogen or estrogen/progestin regimes on heart disease risk factors in post menopausal women. JAMA 1995; 273: 199-208.
4. Colditz GA, Hankinson SE, Hunter D, et al. The use of estrogens and progestins and the risk of breast cancer in post menopausal women. N Engl J Med 1995; 332: 1589-1593.
5. Daly E, Roche M, Barlow D, et al. Hormone replacement therapy: an analysis of benefits, risks and costs. Br Med Bull 1992; 48: 368-400.
6. Belchetz PE. Hormonal treatment of postmenopausal women. N Engl J Med 1994; 330: 1062-1071.
7. Davidson NE. Hormone replacement therapy - Breast versus heart versus bone. N Engl J Med 1995; 332: 1638-1639.
8. Medical Research Council General Practice Research Framework. Randomised comparison of oestrogen versus oestrogen plus progestogen hormone replacement therapy in women with hysterectomy. BMJ 1996; 312: 473-478.
9. Monthly Index of Medical Specialties. London: Haymarket Medical Ltd, April 1980-March 1995.
10. Persson I, Adams HO, Lindberg BS, et al. Practice and patterns of estrogen treatment in climacteric women in a Swedish population. Acta Obstet Gynecol Scand 1983; 62: 289-296.
11. Kennedy D, Baum C, Forbes M. Non contraceptive estrogens and progestins: use patterns over time. Obstet Gynaecol 1985; 65: 441-447.
12. Adam S, Williams V, Vessey MP. Cardiovascular disease and hormone replacement treatment: a pilot case-control study. BMJ 1981; 282: 1277-1278.
13. Hannaford PC, Mant DC, Vessey MP. Hormone replacement therapy in general practice. BMJ 1991; 302: 1602.
14. Wilkes HC, Meade TW. Hormone replacement therapy in general practice: a survey of doctors in the MRC's general practice research framework. BMJ 1991; 302: 1317-1320.
15. Paivi T, Klaukka T, Hemminki E, Uutela A. Use of hormone replacement therapy in 1976-89 by 45-64 year-old Finnish women. J Epidemiol Community Health 1991; 45: 277-280.
16. US Congress, Office of Technology Assessment. The menopause, hormone therapy, and women's health. [OTA-BP-BA-88.] Washington, DC: US Government Printing Office, 1992.
17. Griffiths F, Convery B. Women's use of hormone replacement therapy for relief of menopausal symptoms, for prevention of osteoporosis, and after hysterectomy. Br J Gen Pract 1995; 45: 355-358.
18. Weiss NS, Szekely DR, Austin DF. Increasing incidence of endometrial cancer in the United States. N Engl J Med 1976; 294: 1259.